Khan Taj Ali, Ul Haq Ihtisham, Hinthong Woranich, Campino Susana, Gohar Aisha, Khan Noman, Kashif Muhammad, Ullah Ihsan, Clark Taane G
Institute of Pathology and Diagnostic Medicines, IPDM, Khyber Medical University Peshawar, Peshawar 25000, Pakistan.
Emerging Pathogens Institute, University of Florida, Gainesville, FL 32611, USA.
Pathogens. 2025 Jan 15;14(1):79. doi: 10.3390/pathogens14010079.
The emergence of hypervirulent and carbapenem-resistant hypermucoviscous strains presents a significant public health challenge due to their increased virulence and resistance to multiple antibiotics. This study evaluates the antibiotic susceptibility patterns and virulence profiles of classical and hypervirulent strains isolated from various clinical samples. A total of 500 clinical samples were collected from patients at the Mardan Medical Complex and Ayub Medical Complex in KPK between July 2022 and June 2024. Among these, 64 strains were isolated and subsequently subjected to antimicrobial susceptibility testing (AST) and phenotypic virulence detection. Among the 64 isolates, 21 (32.8%) exhibited hypermucoviscosity, a characteristic associated with increased pathogenicity. Hemagglutination was observed in 35 (54.1%) of the isolates, indicating the presence of surface adhesins that facilitate bacterial adherence to host tissues. A high prevalence of biofilm formation was noted, with 54 (84%) isolates capable of forming biofilms, which are known to protect bacteria from antibiotics and the host immune response. Most isolates (59/64, 92.1%) were resistant against ampicillin, highlighting its limited efficacy against these strains. Conversely, the lowest resistance was observed for tigecycline, with only 15% (10/64) of the isolates showing resistance, indicating its potential utility as a treatment option. The study also found that 38 (59.3%) of the isolates were extended-spectrum beta-lactamase (ESBL) producers, 42 (65.6%) were multidrug-resistant (MDR), 32 (50%) were extensively drug-resistant (XDR), and 13 (20.3%) were resistant to carbapenems. The genetic study revealed biofilm producer and enhancer genes (, , , , , , and ) mainly in the hypervirulent strains. These hypervirulent strains also show a high number of resistance genes. The findings of this study underscore the critical need for the active surveillance of antimicrobial resistance and virulence determinants in . The coexistence of high levels of antibiotic resistance and virulence factors in these isolates poses a severe threat to public health, as it can lead to difficult-to-treat infections and increased morbidity and mortality.
高毒力和耐碳青霉烯的高黏液性菌株的出现对公共卫生构成了重大挑战,因为它们的毒力增强且对多种抗生素具有耐药性。本研究评估了从各种临床样本中分离出的经典菌株和高毒力菌株的抗生素敏感性模式和毒力特征。2022年7月至2024年6月期间,从开伯尔-普赫图赫瓦省马尔丹医疗中心和阿尤布医疗中心的患者中总共收集了500份临床样本。其中,分离出64株菌株,随后对其进行抗菌药物敏感性测试(AST)和表型毒力检测。在这64株分离株中,21株(32.8%)表现出高黏液性,这一特征与致病性增加有关。35株(54.1%)分离株观察到血凝现象,表明存在有助于细菌黏附于宿主组织的表面黏附素。注意到生物膜形成的高发生率,54株(84%)分离株能够形成生物膜,已知生物膜可保护细菌免受抗生素和宿主免疫反应的影响。大多数分离株(59/64,92.1%)对氨苄西林耐药,突出了其对这些菌株疗效有限。相反,替加环素的耐药率最低,只有15%(10/64)的分离株显示耐药,表明其作为治疗选择的潜在效用。该研究还发现,38株(59.3%)分离株是超广谱β-内酰胺酶(ESBL)产生菌,42株(65.6%)是多重耐药(MDR)菌,32株(50%)是广泛耐药(XDR)菌,13株(20.3%)对碳青霉烯类耐药。基因研究揭示生物膜产生和增强基因(、、、、、和)主要存在于高毒力菌株中。这些高毒力菌株还显示出大量耐药基因。本研究结果强调了对[具体细菌名称未给出]中抗菌药物耐药性和毒力决定因素进行主动监测的迫切需求。这些分离株中高水平抗生素耐药性和毒力因子的共存对公共卫生构成了严重威胁,因为它可导致难以治疗的感染以及发病率和死亡率增加。